MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-2201

  1. 969 Posts.
    lightbulb Created with Sketch. 74
    SFU professor's invention approved by FDA to help wean COVID-19 patients from ventilators

    “The system’s goal is to enable and accelerate the recovery of ventilated patients, reduce the hospital care cost of critically ill patients, improve the lifespan and quality of life of survivors of mechanical ventilation and save ICU patients’ lives.”

    https://apple.news/ACnRhHPTiSMWvDlnAOnp0TQ

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.